Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight

globenewswire.com
JNJ PFE ABBV LLY AMGN INCY GILD BHC AZN SUN

Erin Lichy Gets Real About Her Natrelle® Breast Augmentation

prnewswire.com
ABBV

SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key Challenger to GSK’s Benlysta

globenewswire.com
GSK AZN BIIB BMY ABBV

Neomorph Announces Closing of $100 Million Series B Financing

globenewswire.com
NVO BIIB ABBV

Antibody Drug Conjugates (ADC) Market Research and Competitive Landscape Report 2026 - Extensive Analysis of Over 180 Companies and More Than 290 Drugs

globenewswire.com
GILD ABBV IPHA

Follicular Lymphoma Market Insight, Epidemiology, and Forecasts, 2022-2026 & 2026-2036

globenewswire.com
AZN GILD ABBV REGN BIIB

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

prnewswire.com
ABBV

AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

prnewswire.com
ABBV

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments

globenewswire.com
ABBV GSK AZN GILD REGN

BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through "The Confidence Collective" for Fourth Year

prnewswire.com
ABBV